期刊文献+

鱼精蛋白对PLA微球佐剂的调控 被引量:1

Adjuvant Activity of PLA Microspheres Regulated by Protamine Sulfate
原文传递
导出
摘要 采用快速膜乳化法,以聚乳酸(PLA)为材料,分别以乙酸乙酯和二氯甲烷为有机溶剂,制备了粒径400和900nm的均一PLA微球和鱼精蛋白(PS)修饰的PLA-PS微球,以微球为佐剂、HBsAg为抗原免疫小鼠,在动物水平上研究其免疫调控作用,考察了不同粒径微球对抗原体内免疫效果的影响.结果表明,鱼精蛋白修饰后的PLA微球对乙肝表面抗原的吸附率增加,未修饰的PLA微球对抗原的吸附率仅为2.07%,修饰后吸附率为8.16%;修饰后微球为佐剂的免疫效果优于未修饰微球为佐剂的免疫效果,鱼精蛋白修饰能显著提升小鼠脾细胞分泌Th1型细胞因子(IL-2和IFN-γ)数(分别提升了261%和139%),分泌Th2型细胞因子IL-4数增加了67%;用修饰后平均粒径400 nm微球为佐剂免疫小鼠,IL-2分泌水平是900nm微球为佐剂的1.68倍. Polylactic acid (PLA) microspheres and protamine sulfate (PS) modified PLA microspheres were prepared with ethyl acetate (for 400 nm diameter) or dichloromethane (for 900 nm diameter) by premix membrane emulsification method. BALB/c mice were used to evaluate the adjuvanticity of as-prepared microparticles for HBsAg, and the effect of particles size on their adjuvanticity was investigated. The results indicated that PS modification significantly promoted the adsorption of HBsAg onto the microspheres, and the adsorption rate was increased to 8.16% from 2.07%. Compared with PLA microspheres, PS modified microspheres induced more potent immune response, the spot formation cells (SFCs) of IL-2 and IFN-y (Th 1 type cytokine) were increased 261% and 139%, respectively. The SFCs of IL-4 secretion of Tb_2 type cytokine were also enhanced by 67%. Immune effect of different sizes of PLA-PS microspheres demonstrated that the secretion level of IL-2 for 400 nm microspheres was 1.68 times to the counterparts of 900 nm microspheres.
出处 《过程工程学报》 CAS CSCD 北大核心 2013年第4期646-653,共8页 The Chinese Journal of Process Engineering
基金 中国科学院知识创新工程基金资助项目(编号:KSCX2-EW-R-19) 国家高技术研究发展计划(863)基金资助项目(编号:2012AA02A406)
关键词 PLA微球 鱼精蛋白 佐剂 膜乳化 polylactic acid microsphere protamine sulfate adjuvant membrane emulsification
  • 相关文献

参考文献35

  • 1Tiollais P, Pourcel C, Dejean A. The Hepatitis B Virus [J]. Nature,1985,317(5): 489495.
  • 2田拥军,覃莉,张正茂,李磊,雷延昌,喻植群,赵西平,杨东亮.稳定表达乙型肝炎病毒G145R变异表面抗原细胞系的建立[J].中国病毒学,2005,20(6):574-577. 被引量:9
  • 3Allsop C E M, Plebanski M, Gilbert S, et al. Comparison of NumerousDelivery Systems for the Induction of Cytotoxic T Lymphocytes byImmunization [J]. Eur. J. Immunol., 1996, 26: 1951-1959.
  • 4Stanbeny L R,Spruance S L, Cunningham A L, et al.Glycoprotein-D-adjuvant Vaccine to Prevent Genital Herpes [J]. NewEngland J. Med., 2002,347(21): 1652-1661.
  • 5Chisari F V, Ferrari C. Hepatitis B Virus Immunopathogenesis [J].Annu. Rev. Immunol., 1995, 13: 29-60.
  • 6Sahoo S K, Panda A K, Labhasetwar V. Characterization of PorousPLGA/PLA Microparticles as a Scaffold for Three DimensionalGrowth of Breast Cancer Cells [J]. Biomacromolecules, 2005,6(2):1132-1139.
  • 7Lassalle V,Ferreira M L. PLA Nano- and Microparticles for DrugDelivery: An Overview of the Methods of Preparation [J]. Macromol.Biosci.,2007, 7(6): 767-783.
  • 8Wischke C,Schwendeman S P. Principles of EncapsulatingHydrophobic Drugs in PLA/PLGA Microparticles [J]. Int. J. Pharm.,2008,364(2): 298-32.
  • 9Biggs D L, Lengsfeld C S, Hybertson B M, et al. In vitro and in vivoEvaluation of the Effects of PLA Microparticle Crystallinity onCellular Response [J]. J. Controlled Release, 2003, 92(1): 147-161.
  • 10Singh M, Briones M, Ott Q et al. Cationic Microparticles: A PotentDelivery System for DNA Vaccines [J]. Proceedings of the NationalAcademy of Sciences,2000,97(2): 811-816.

二级参考文献31

  • 1Couvreur P,Blanco-Prieto M J,Puisieux F.Multiple Emulsion Technology for the Design of Microspheres Containing Peptides and Oligopeptides[J].Adv.Drag Del.Rev.,1997,28(1):85-87.
  • 2Peragini P,Genta I,Pavanetto F.Study on Glycolic Acid Delivery by Liposomes and Microspheres[J].Int.J.Pharm.,2000,196(1):51-61.
  • 3Jintapattanakit A,Junyaprasert V B,Sitterberg J,et al.Peroral Delivery of Insulin Using Chitosan Derivatives:A Comparative Study of Polyelectrolyte Nanocomplexes and Nanoparticles[J].Int.J.Pharm.,2007,342(1/2):240-249.
  • 4Kamei N,Morishita M,Ehara J,et al.Permeation Characteristics of Oligoarginine through Intestinal Epithelium and Its Usefulness for Intestinal Peptide Drug Delivery[J].J.Controlled Release,2008,131(2):94-99.
  • 5Russ V,Gunther M,Halama A,et al.Oligoethylenimine-grafted Polypropylenimine Dendrimers as Degradable and Biocompatible Synthetic Vectors for Gene Delivery[J].J.Controlled Release,2008,132(2):131-140.
  • 6Putney S D.Encapsulation of Proteins for Improved Delivery[J].Curr.Opin.Chem.Biol.,1998,2(4):548-552.
  • 7Miyata T,Uragami T,Nakamae K.Biomolecule-sensitive Hydrogels[J].Adv.Drug Del.Rev.,2002,54(1):79-98.
  • 8Vila A,Sanchez A,Tobio M,et al.Design of Biodegradable Particles for Protein Delivery[J].J.Controlled Release,2002,78(1):15-24.
  • 9Li X H,Zhou S B,Wu X R.Poly-DL-lactide-poly-(ethylene glycol) Microspheres as Oral and Parenteral Delivery Systems for Hepatitis B Antigen[J].J.Appl.Polym.Sci.,2002,83(4):850-856.
  • 10Weissenbock A,Wirth M,Gabor F.WGA-grafted PLGA Nanospheres:Preparation and Association with Caco-2 Single Cells[J].J.Controlled Release,2004,99(3):383-392.

共引文献9

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部